Bengaluru — Clinical trials of AstraZeneca and Oxford University's experimental Covid-19 vaccine have resumed in Japan, almost a month after being put on hold due to an illness of a British volunteer, while discussions with US authorities continue.
Global trials of the vaccine, called AZD1222 or ChAdOx1 nCoV-19, were put on hold on September 6 after a study participant fell ill with what was believed to be a rare spinal inflammatory disorder called transverse myelitis. AstraZeneca has called the halt a standard review procedure, and a document posted online by Oxford university last month stated the illness may not have been associated with the vaccine.
The US Food and Drug Administration broadened its investigation of the illness in the volunteer, and would look at data from earlier trials of similar vaccines developed by the same scientists, three sources told Reuters.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Phase 3 trials of Covid-19 vaccine to begin in SAPhase 3 clinical trials for a potential Covid-19 vaccine candidate are set to commence in South Africa.
Source: IOL - 🏆 46. / 51 Read more »
Centralised global network to compare Covid-19 vaccinesLaboratories will centralise analysis of samples from trials of Covid-19 candidates
Source: BDliveSA - 🏆 12. / 63 Read more »
Tokyo Stock Exchange outage dents Japan’s goal of becoming a global financial hubThe unprecedented outage scrapped trading for an entire day, making it unlikely to win points among foreign executives
Source: BDliveSA - 🏆 12. / 63 Read more »